Are We Over-Treating With Checkpoint Inhibitors?

British Journal of Cancer - United Kingdom
doi 10.1038/s41416-019-0570-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC